Ammodaucus leucotrichus Acts as an Antihypertensive and Vasorelaxant Agent Through sGC and Prostaglandin Synthesis Pathways.

Q2 Medicine
Smail Amtaghri, Miloudia Slaoui, Mohamed Eddouks
{"title":"<i>Ammodaucus leucotrichus</i> Acts as an Antihypertensive and Vasorelaxant Agent Through sGC and Prostaglandin Synthesis Pathways.","authors":"Smail Amtaghri,&nbsp;Miloudia Slaoui,&nbsp;Mohamed Eddouks","doi":"10.2174/1871525721666221209161605","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Ammodaucus leucotrichus</i> is a medicinal plant used in traditional medicine to treat various ailments, including hypertension.</p><p><strong>Aims: </strong>The study aimed to determine the antihypertensive activity of <i>Ammodaucus leucotrichus</i>.</p><p><strong>Objective: </strong>The study aimed to investigate the antihypertensive and vasorelaxant activities of the aqueous extract of <i>Ammodaucus leucotrichus</i> fruits (ALAE) in rats.</p><p><strong>Methods: </strong>ALAE was prepared to study its antihypertensive effect in L-NAME (Nω-L-arginine methyl ester)-induced hypertensive rats and its vasorelaxant activity in isolated thoracic aortas of rats. The acute and subchronic effects of ALAE on systolic, diastolic, mean arterial pressure, and heart rate (HR) were evaluated after oral administration of ALAE (60 and 100 mg/kg body weight) for 6 h for the acute experiment and over 7 days for the subchronic test. Isolated thoracic aortic rings were prepared to examine the vasorelaxant action of ALAE. Several common pharmacological agents were used to test potential pathways implicated in vasorelaxant action.</p><p><strong>Results: </strong>The results showed that ALAE reduced blood pressure parameters (systolic, mean, and diastolic blood pressure) in L-NAME-induced hypertension rats after repeated oral treatment over seven days without affecting normotensive rats. Furthermore, in thoracic aortic rings pre-contracted with epinephrine (EP) (10 μM) or KCl (80 mM), ALAE (0.250-1.625 mg/ml) showed a vasorelaxant effect. In isolated rat thoracic aortas, blockage of soluble guanylyl cyslase with blue methylene (P < 0.01) partially decreased this vasorelaxant effect. In addition, blockage of the prostaglandin synthesis pathway with indomethacin (P<0.05) also reduced the vasorelaxant activity of ALAE. Pretreatment of aortic rings with glibenclamide, propanolol, L-NAME, MLN-4760, or nifedipine did not affect ALAE-induced vasorelaxation.</p><p><strong>Conclusion: </strong><i>Ammodaucus leucotrichus</i> is a prescient medicinal plant, able to act as an antihypertensive agent. Moreover, the results suggest that the extract increased cGMP in NO-independent manner.</p>","PeriodicalId":9535,"journal":{"name":"Cardiovascular and Hematological Agents in Medicinal Chemistry","volume":"21 3","pages":"177-192"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular and Hematological Agents in Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871525721666221209161605","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ammodaucus leucotrichus is a medicinal plant used in traditional medicine to treat various ailments, including hypertension.

Aims: The study aimed to determine the antihypertensive activity of Ammodaucus leucotrichus.

Objective: The study aimed to investigate the antihypertensive and vasorelaxant activities of the aqueous extract of Ammodaucus leucotrichus fruits (ALAE) in rats.

Methods: ALAE was prepared to study its antihypertensive effect in L-NAME (Nω-L-arginine methyl ester)-induced hypertensive rats and its vasorelaxant activity in isolated thoracic aortas of rats. The acute and subchronic effects of ALAE on systolic, diastolic, mean arterial pressure, and heart rate (HR) were evaluated after oral administration of ALAE (60 and 100 mg/kg body weight) for 6 h for the acute experiment and over 7 days for the subchronic test. Isolated thoracic aortic rings were prepared to examine the vasorelaxant action of ALAE. Several common pharmacological agents were used to test potential pathways implicated in vasorelaxant action.

Results: The results showed that ALAE reduced blood pressure parameters (systolic, mean, and diastolic blood pressure) in L-NAME-induced hypertension rats after repeated oral treatment over seven days without affecting normotensive rats. Furthermore, in thoracic aortic rings pre-contracted with epinephrine (EP) (10 μM) or KCl (80 mM), ALAE (0.250-1.625 mg/ml) showed a vasorelaxant effect. In isolated rat thoracic aortas, blockage of soluble guanylyl cyslase with blue methylene (P < 0.01) partially decreased this vasorelaxant effect. In addition, blockage of the prostaglandin synthesis pathway with indomethacin (P<0.05) also reduced the vasorelaxant activity of ALAE. Pretreatment of aortic rings with glibenclamide, propanolol, L-NAME, MLN-4760, or nifedipine did not affect ALAE-induced vasorelaxation.

Conclusion: Ammodaucus leucotrichus is a prescient medicinal plant, able to act as an antihypertensive agent. Moreover, the results suggest that the extract increased cGMP in NO-independent manner.

白毛杉通过sGC和前列腺素合成途径作为抗高血压和血管松弛剂。
背景:白毛杉(Ammodaucus leucotrichus)是一种药用植物,在传统医学中用于治疗各种疾病,包括高血压。目的:研究白毛杉的降压作用。目的:研究毛杉果水提物(ALAE)对大鼠的降压和血管松弛作用。方法:制备ALAE,研究其对L-NAME (n ω- l -精氨酸甲酯)诱导的高血压大鼠的降压作用及对离体大鼠胸主动脉的血管松弛活性。在急性实验中口服ALAE(60和100 mg/kg体重)6小时,在亚慢性试验中口服ALAE超过7天,评估ALAE对收缩压、舒张压、平均动脉压和心率(HR)的急性和亚慢性影响。制备离体胸主动脉环,观察ALAE的血管松弛作用。几种常见的药理学药物被用来测试涉及血管松弛作用的潜在途径。结果:结果表明,ALAE可降低l - name诱导高血压大鼠的血压参数(收缩压、平均压和舒张压),且对正常大鼠无影响。此外,在肾上腺素(EP) (10 μM)或KCl (80 mM)预收缩的胸主动脉环中,ALAE (0.250 ~ 1.625 mg/ml)表现出血管松弛作用。在离体大鼠胸主动脉中,蓝亚甲基阻断可溶性胍基酰基化酶(P < 0.01)可部分降低这种血管松弛作用。结论:白毛杉是一种有先见之明的药用植物,具有抗高血压的作用。此外,结果表明,该提取物以no独立的方式增加cGMP。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular and Hematological Agents in Medicinal Chemistry
Cardiovascular and Hematological Agents in Medicinal Chemistry Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.70
自引率
0.00%
发文量
34
期刊介绍: Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry. Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信